
Results
2
2 companies
Kuros Biosciences
Market Cap: CHF 794.5m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURN
CHF 20.28
7D
-8.0%
1Y
-28.6%
Cosmo
Market Cap: CHF 1.3b
A life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally.
COPN
CHF 82.00
7D
-9.5%
1Y
69.6%